Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement
The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Abstract
DESCRIPTION: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. METHODS: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. POPULATION: This recommendation applies to adults aged 40 to 70 years seen in primary care settings who do not have symptoms of diabetes and are overweight or obese. RECOMMENDATION: The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (B recommendation).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intensive Behavioral Counseling (IBC) interventions like the National Diabetes Prevention Program (NDPP), have demonstrated effectiveness in reducing excess body weight and lowering or delaying morbidity onset.”
In the citing paper
“Intensive Behavioral Counseling (IBC) has been widely accepted as an effective approach for compliant individuals to reduce body weight, improve clinical measures, and lower risk of obesity-related comorbidities [1–6].”
In the citing paper
“The US Preventive Services Task Force (USPSTF) recommends that, as part of cardiovascular diseases (CVD) risk assessment, all overweight and obese adults between age 40 and 70 be screened for abnormal blood glucose, and those with CVD risk factors (e.g., hypertension, dyslipidemia, prediabetes) be referred for IBC, such as programs modeled on the National Diabetes Prevention Program (NDPP) [3,5].”
In the citing paper
“All individuals met the USPSTF criteria for receiving IBC because they had CVD risk factors independent of excess body weight; with 997 (89%) also meeting the CDC and NDPP recommendations for intervention due to prediabetes [3,5,17].”
In the citing paper
“Previous work has found that IBC intervention, including NDPP, among overweight and obese adults with prediabetes and CVD risk factors can improve clinical measures, prevent or delay disease onset, reduce medical expenditures, and increase productivity (in the form of higher labor force participation and lower work absenteeism) [1–6,13–15,19].”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“The Diabetes Prevention Program (11), conducted in the United States in 3234 participants, found that an intensive lifestyle modification intervention was associated with better quality of life at 3-year follow-up.”
BackgroundStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465 · cited 1×
“Similarly, the Steno-2 Study (31) showed a reduction in all-cause mortality (RR, 0.”
BackgroundEffects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600 · cited 3×
“One Finnish (12) and 1 Chinese (13) trial, each with more than 500 participants, suggested improvements in all-cause mortality outcomes after 10 and 20 years, respectively (HR, 0.”
BackgroundInfluential
Research works printed but not linked: 3
- Mortaz S, 2012, Clinicoecon Outcomes Res, 4, 91
- Hemmingsen B, 2013, Cochrane Database Syst Rev, 11, CD008143
- American Diabetes Association, 2015, Diabetes Care, 38, S1
Cited by
Items 201–300 of 321
Taylor, J. S., Fellman, B. M., Cain, K. E., Iniesta, M. D., Earles, T., Harris, M., James, D., Siebel, C., Lasala, J., Mena, G. E., et al. (2024) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2024.100003 · Cited by 6
Type 2 diabetes mellitus screening rates in racial and ethnic minority groups
Joy, A. J., Duckworth, L., & Scarton, L. J. (2022) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000687 · Cited by 4
“Preventative Services Task Force (USPSTF), current guidelines recommend all adults be screened for T2DM between the ages of 40 and 70 years (Siu, 2015).”
BackgroundMethodDing, H., Huang, J., Deng, Y., Tin, S. P. P., Wong, M. C. S., & Yeoh, E. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055764 · Cited by 5
Kosho, M. X. F., Verhelst, A. R. E., Teeuw, W. J., van Bruchem, S., Nazmi, K., Gerdes, V. E. A., & Loos, B. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247512 · Cited by 5
How Effective is a Simple Pre-Diabetes Screen for Clinical Practice?
James, K. S., & Matsangas, P. (2016) · Journal of Clinical Nutrition & Dietetics · doi:10.4172/2472-1921.100019 · Cited by 4
Altuve, M., & Severeyn, É. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.05.029 · Cited by 3
Karakonstantis, S., Kassotaki, I., Korela, D., Arna, D., Milaki, K., Tsigaridaki, M., Lydakis, C., & Pappas, A. C. (2019) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2019-0015 · Cited by 5
Diabetes Knowledge, Behaviors, and Perceptions of Risk in Rural West Virginia Counties
Misra, R., Farjo, S., McGinnis, R., Elavsky, M. A., Kuhn, S. L., & Morton-McSwain, C. (2021) · PubMed · doi:10.13023/jah.0303.05 · Cited by 6
Obesity 2021: Current Clinical Management of a Chronic, Serious Disease
Kushner (2021) · The Journal of Family Practice · doi:10.12788/jfp.0221 · Cited by 8
Lenoir, K. M., Sandberg, J. C., MILLER, D. P., & Wells, B. J. (2022) · JMIR Formative Research · doi:10.2196/41011 · Cited by 4
Improving Diabetes Screening in the Primary Care Clinic
Tseng, E., Hsu, Y., Nigrin, C., Clark, J. M., Marsteller, J. A., & Maruthur, N. M. (2023) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/j.jcjq.2023.07.009 · Cited by 6
Practical Tips for Implementing the Diabetes Prevention Program in Clinical Practice
Jasik, C. B., Joy, E. A., Brunisholz, K. D., & Kirley, K. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1034-0 · Cited by 6
Timboe, A. M., Lystrup, R. M., Ledford, C. J. W., & Crawford, P. F. (2018) · Military Medicine · doi:10.1093/milmed/usy207 · Cited by 4
Screening for Autoantibodies in Type 1 Diabetes: A Call to Action
Петерс (2021) · The Journal of Family Practice · doi:10.12788/jfp.0223 · Cited by 11
“For instance, in 2015, the US Preventive Services Task Force recommended against performing routine serum islet autoantibody screening for T1D.(1) Nevertheless, results from the more recent Fr1da study(2,3) (see below) suggest that substantial health benefits may accrue from general population screening for islet auto…”
BackgroundInfluentialGhouse, A., Gunther, W., & Sebastian, M. (2020) · Spartan Medical Research Journal · doi:10.51894/001c.17649 · Cited by 4
Visaria, A., Islam, S., Polamarasetti, P., James, J., Raju, P., Sharma, A., Khangura, K. K., Thawani, R., & Dodani, S. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106761 · Cited by 4
Chaves, K. F., Panza, J., Olorunfemi, M. A., Helou, C. M., Apple, A., Zhao, Z., Sorabella, L. L., Dumas, S. D., Adam, R. A., & Prescott, L. S. (2023) · Perioperative Medicine · doi:10.1186/s13741-023-00307-1 · Cited by 6
“Additionally, a blood glucose ≥ 140 g/dL after a 75-g carbohydrate load defines impaired glucose tolerance (American Diabetes Association 2019; Siu 2015).”
BackgroundMethodInfluentialReducing Health Disparities Through Prevention: Role of the U.S. Preventive Services Task Force
O’Brien, M. J., Kirley, K., & Ackermann, R. T. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.11.022 · Cited by 3
Pazin, D. C., da Matta, S. S., Faria‐Neto, J. R., & Bloch, K. V. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0191 · Cited by 3
Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals
Hardatt, D., Devi, M., Vyas, S., Singh, G., Jain, J., Gupta, S., & Dhanawat, M. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230331083715 · Cited by 3
O’Brien, M. J., Bailey, S. C., Gregory, D. L., Owen, A. L., Khan, S. S., Ackermann, R. T., Hassan, A., Mohanty, N., & Bowen, M. E. (2023) · Journal of General Internal Medicine · doi:10.1007/s11606-023-08402-1 · Cited by 11
“This lowered the screening age from 40–70 years in the USP-STF’s prior 2015 screening recommendation, 8 which represents the only change to the guideline.”
BackgroundUtilisation of cardiovascular preventive services in a rheumatoid arthritis population-based cohort
Montes, D., Hulshizer, C. A., Myasoedova, E., Davis, J. M., Hanson, A. C., Duarte‐García, A., Figueroa‐Parra, G., Chevet, B., & Crowson, C. S. (2023) · RMD Open · doi:10.1136/rmdopen-2023-003318 · Cited by 4
Smetana, G. W., Abrahamson, M. J., & Rind, D. M. (2016) · Annals of Internal Medicine · doi:10.7326/m16-1091 · Cited by 5
Lukić, I., Savić, N., Simic, M., Ranković, N., Ranković, D., & Lazić, L. (2021) · Medicina · doi:10.3390/medicina58010009 · Cited by 6
“It is important for each individual but also for society as a whole [23].”
BackgroundComprehensive Geriatric Assessment
Dharmarajan, T. S. (2021) · Springer eBooks · doi:10.1007/978-3-319-90761-1_8-1 · Cited by 6
Two in One: Diagnosing Type 2 Diabetes With Single-Sample Testing
Narayan, K. M. V., & Jagannathan, R. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1477 · Cited by 3
Diabetes screening revisited: issues related to implementation
Wong, M. C. S., Huang, J., & Kong, A. P. S. (2020) · Hong Kong Medical Journal · doi:10.12809/hkmj205103 · Cited by 3
López, A. A. P., Chávez-Negrete, A., Rodríguez-Lozano, A. L., Gómez-Alarcón, Á. J., Montaño-Velázquez, B. B., Hinojosa, C. A., Sánchez-Hernández, C., Pimentel-Hernández, C., Dehesa-López, E., Romero-Moreno, F., et al. (2026) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.m23000030 · Cited by 9
Sowmya, R., Supriya, V., Rajkumar, M., & Silambuselvi, K. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112381 · Cited by 5
Fundamentals of Biomarkers and Biosensors for Precision Healthcare
Chen, C., & Li, L. (2025) · Springer eBooks · doi:10.1007/978-981-95-2117-3_3 · Cited by 2
Metformin prescription for U.S. veterans with prediabetes, 2010–2019
Gulanski, B., Goulet, J. L., Radhakrishnan, K., Ko, J., Li, Y., Rajeevan, N., Lee, K. M., Heberer, K. R., Lynch, J. A., Streja, E., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231201141 · Cited by 2
“48 For those with abnormal glucose levels, USPSTF recommended referral for intensive behavioral counseling for healthful diet and physical activity and cited insufficient evidence for pharmacologic treatment.”
BackgroundMoqueet, N., Cornacchi, S. D., Antony, J., Khalil, I., Manca, D. P., Fernandes, C., Paszat, L. F., Aubrey‐Bassler, K., Grunfeld, E., Sopcak, N., et al. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02471-9 · Cited by 5
Cabaluna, I. T. G., Villarruz-Sulit, M. V., Legaspi, K. E. Y., & Dans, L. F. (2024) · Clinical and Public Health Guidelines · doi:10.1002/gin2.70008 · Cited by 2
Surface Plasmon Resonance Sensor Based on Ag@CoO/Ag Nanoflower Material
Wang, Q., Zheng, H., Xu, Y., Guo, L., & Sang, J. (2025) · Plasmonics · doi:10.1007/s11468-025-02808-9 · Cited by 2
“They assist in the early detection of abnormal blood glucose levels, facilitate timely interventions, and help prevent the onset of diabetes [23–25].”
Diabetes Mellitus Type 2 Screening Guidelines
Isfeedvajani, M. S. (2018) · International Journal of Medical Reviews · doi:10.29252/ijmr-050401 · Cited by 2
Amirthalingam, P. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2020.v13i2.36404 · Cited by 2
Do descendants of families contribute to type 2 diabetes mellitus?
Nuraisyah, F., Solikhah, S., & Ruliyandari, R. (2020) · International Journal of Public Health Science (IJPHS) · doi:10.11591/ijphs.v9i4.20586 · Cited by 3
“Individuals with high glucose levels/hyperglycemic are significantly higher risk factor T2DM than glucose average [20, 21].”
BackgroundDiabetes and hypertension screening in Zandspruit, Johannesburg 2012–2014
Rheeder, P., Muthembe, T., Lawson, S., & Brink, J. (2016) · South African Family Practice · doi:10.1080/20786190.2016.1198089 · Cited by 2
Low Screening Rates for Diabetes Mellitus Among Family Members of Affected Relatives.
Polubriaginof, F. C. G., Shang, N., Hripcsak, G. M., Tatonetti, N. P., & Vawdrey, D. K. (2018) · Europe PMC (PubMed Central) · Cited by 2
Healthful Physical Activity and Diet Promotion—For the Many or the Few?
Spring, B. J. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2568 · Cited by 2
Manicardi, V., Vicentini, M., Ballotari, P., Venturelli, F., & Rossi, P. G. (2019) · Diabetes Care · doi:10.2337/dc18-2175 · Cited by 2
Selçuk, E. B., Tetik, B. K., & KARATAS, M. (2015) · Turkish Journal of Family Medicine & Primary Care · doi:10.5455/tjfmpc.175160 · Cited by 1
Change in testing for blood glucose during the COVID-19 pandemic, United States 2019–2021
Miyamoto, Y., Saelee, R., Koyama, A. K., Zaganjor, I., Xu, F. Z., Onufrak, S. J., & Pavkov, M. E. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110985 · Cited by 1
Thomas, T., Finertie, H., Sanchez, P. E., Rodríguez, L. A., & Schmittdiel, J. A. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102850 · Cited by 2
“This is a shift from the 2015 recommendation that advised referral to ‘intensive behavioral interventions ’ (i.e., NDPP) for patients with prediabetes (Siu, 2015).”
BackgroundDiabetes Mellitus—What to Consider for Total Hip and Knee Arthroplasty
Stimolo, D., & Hirschmann, M. T. (2024) · Springer eBooks · doi:10.1007/978-3-031-57220-3_20 · Cited by 1
Melake, A., & Nakachew, E. (2025) · Scientific Reports · doi:10.1038/s41598-025-12355-2 · Cited by 1
Orlando, F. A., Liu-Galvin, R. E., Miller, A. M., Naous, J., Governale, K. M., Tudeen, M., Schmidt, S. O., Saguil, A. A., & Mainous, A. G. (2025) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2025.108177 · Cited by 1
Alrossies, A. S., Alsubaie, N., Shah, Z. A., Ilyas, M., Habib, I., Saddique, G., & Shah, S. M. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1735170 · Cited by 3
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus
Barkoudah, E., & Weinrauch, L. A. (2016) · Annals of Internal Medicine · doi:10.7326/l16-0100 · Cited by 1
Stuenkel, C. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-42451-4_15 · Cited by 1
Genc, O., Aksu‐Menges, E., Kilit, T. P., Koçak, F. E., Korkut, Y., & Onbaşı, K. (2018) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2018.59013 · Cited by 1
“Glucosuria (mg/dL), N (%) Negative (< 50 mg/dL) + (> 50 - < 150 mg/dL) ++ (> 150 - < 500 mg/dL) +++ (> 500 mg/dL) 194 (93) 2 (1) 2 (1) 10 (5) 208 (100) 0 0 0 < 0.”
BackgroundGreiner, B. H., Mercer, H., Raymond, C., Sonstein, L. K., & Hartwell, M. L. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108376 · Cited by 1
Yun, J. M., Choi, S., Kım, K., Kim, S.-S., Son, J. S., Lee, G., Jeong, S., Park, S. Y., Kim, Y.-R., & Park, S. M. (2020) · Public Health · doi:10.1016/j.puhe.2020.10.023 · Cited by 1
Experts’ opinion on the detection and management of prediabetes in Lebanon
Andari, E., Atallah, P., Azar, S. T., Echtay, A. S., Jambart, S., Saab, C., Howlett, H. C. S., & Al-Naqshbandi, M. (2021) · Science Progress · doi:10.1177/00368504211029439 · Cited by 2
New Perspectives in COPD Management
Yawn (2021) · The Journal of Family Practice · doi:10.12788/jfp.0220 · Cited by 2
Blackman, S. M., & Kelly, A. T. (2016) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(16)00019-9 · Cited by 1
Surgical site infection prevention
Taylor, J. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91208-2.00004-4 · Cited by 1
Screening, Risikostratifizierung und CT-Bildgebung zur Abklärung der koronaren Herzkrankheit
Bischoff, L. M., & Luetkens, J. A. (2024) · Die Radiologie · doi:10.1007/s00117-024-01287-z · Cited by 1
The Impact of Medicaid Expansion on Acute Diabetes Complication by Care Delivery Settings
Kulbak, D., Dinh, D., Larson, A. E., Suchocki, A., Springer, R. J., Marino, M., DeVoe, J. E., Hwang, J. H., & Huguet, N. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319251320161 · Cited by 1
Poon, P. K.-M., Tam, K. W., Yip, B. H. K., Chung, R. Y., Lee, E. K. P., & Wong, S. Y. S. (2025) · BMC Public Health · doi:10.1186/s12889-025-22048-0 · Cited by 1
Johnson, K. L. (2016) · UKnowledge (University of Kentucky) · Cited by 1
Soori, H., Mohammadi, M., & Lebni, J. Y. (2019) · Health Education and Health Promotion · doi:10.29252/hehp.7.2.89 · Cited by 1
Diabetes Management in the United States
Ali, M. K., Shah, M. K., & Moin, T. (2019) · Springer eBooks · doi:10.1007/978-3-030-11815-0_17 · Cited by 1
Ambulatory Care Pharmacists’ Perception of Prediabetes
Carris, N. W., Cowart, K., & García, A. S. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190019857844 · Cited by 1
“As shown in Appendix A, survey respondents were given the option to provide qualitative feedback at the end of the survey regarding the prevention of T2DM.”
BackgroundInfluentialChapter 7. Treating Addiction Like a Chronic Illness: A Practical Clinical Model
McCauley, J. L., & McLellan, A. T. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb07 · Cited by 1
Monitoring of Metabolic Syndrome and Cardiovascular Disease in Childhood Cancer Survivors
Temtanakitpaisan, Y., & Saengnipanthkul, S. (2021) · Journal of Adolescent and Young Adult Oncology · doi:10.1089/jayao.2021.0001 · Cited by 4
“75 Instead, the COG recommended glucose screening every 2 years in childhood cancer survivors.”
Chequeo preventivo basado en la evidencia
Plaza, M., Galán, S. M., & Cordero, M. J. (2021) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2021.06.002 · Cited by 8
Decision Points in the Management of Patients with Diabetic Kidney Disease
Weir (2021) · The Journal of Family Practice · doi:10.12788/jfp.0217 · Cited by 1
Utilizing CGM Ambulatory Glucose Profiles to Optimize Diabetes Management
Miller (2021) · The Journal of Family Practice · doi:10.12788/jfp.0226 · Cited by 2
Moqueet, N., Cornacchi, S. D., Antony, J., Khalil, I., Manca, D. P., Fernandes, C., Paszat, L. F., Aubrey‐Bassler, K., Grunfeld, E., Sopcak, N., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3329363/v1 · Cited by 1
A Missed Screening Opportunity for Diabetes
Tseng, E., & Maruthur, N. M. (2017) · Journal of general internal medicine · doi:10.1007/s11606-016-3970-1
Schroeter, S. A. (2016) · DigitalGeorgetown (Georgetown University Library)
Sitnik, D. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-18012017-155950
Primary Care Provider Feedback of Training to Identify and Manage Pre-Diabetes
Orozco, B., Sohler, N., Young, E., Zubatov, Y., Albu, J., Sill, J., & Botta, J. (2017) · Journal of Community Medicine & Health Education · doi:10.4172/2161-0711.1000557
“Since it has been demonstrated that intervening with people at high risk for diabetes can prevent or delay the onset of diabetes [5], the American Diabetes Association [6] and other organizations [7-9] recommend such interventions for those with pre-diabetes.”
BackgroundVa, A. (2018) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909.2018.11.2.077-080
Kruskall, L. J., Esdaile, H., & Young, J. C. (2018) · Advances in Obesity Weight Management & Control · doi:10.15406/aowmc.2018.08.00219
“Annals of Internal Medicine, 163(11), 861–868.”
Whitley, H. P., Hanson, C., Parton, J., & Smith, W. D. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00402-5
Optimizing the Physician Workforce for Care of Patients With Type 2 Diabetes
Pignone, M. P. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3827
Health Maintenance and Preventive Care in Older Adutls with Dementia
Braun, U. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-46398-4_14
Rogers, M. A. M., & Kim, C. (2020) · Yearbook of pediatric endocrinology · doi:10.1530/ey.17.10.1
Early Arteriosclerosis and Its Risk Factors in Prediabetes and New-Onset Diabetes SubjectsPreprint
Liu, X., Liu, L., Wang, R., Jia, X., Liu, B., Ma, N., & Lü, Q. (2020) · Research Square · doi:10.21203/rs.3.rs-107681/v1
Cardiometabolic Risk Reduction: A Review of Clinical Guidelines and the Role of SGLT-2 Inhibitors
Reid (2021) · The Journal of Family Practice · doi:10.12788/jfp.0216
Use of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease
Mottl (2021) · The Journal of Family Practice · doi:10.12788/jfp.0225 · Cited by 3
Improving Shingles Vaccination Rates in Family Medicine
Luther (2021) · The Journal of Family Practice · doi:10.12788/jfp.0218
The Challenge: Finding the Most Appropriate Statin and Dose for Each Patient
Lillo (2021) · The Journal of Family Practice · doi:10.12788/jfp.0224
Update on Cardiovascular Disease Prevention
Kilstrom, J., & Wildermuth, A. (2021) · Physician Assistant Clinics · doi:10.1016/j.cpha.2021.07.003
Malkin, J. D., Alqunaibet, A., Rakić, S., & Alsukait, R. F. (2021) · World Bank, Washington, DC eBooks · doi:10.1596/978-1-4648-1717-5_ch8
The Impact of Managerial Approach to Untreated Type -2 Diabetes using AI Techniques
Sahu, P., & Mantri, J. K. (2021) · International Conference on Computational Intelligence and Computing Applications (ICCICA) · doi:10.1109/iccica52458.2021.9697120
Comprehensive Geriatric Assessment
Dharmarajan, T. S. (2021) · Springer eBooks · doi:10.1007/978-3-319-90761-1_8-2
Berisha, B., Krasniqi, X., Gashi, M., & Vincelj, J. (2019) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.18.03970-0
Geliebter, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-68379-9_6
Systolic blood pressure and all-cause mortality in normoglycemia, prediabetes, and diabetesPreprint
Chen, C., Liu, L., Huang, J., Yu, Y., Lo, K., Huang, Y., & Feng, Y. (2020) · doi:10.21203/rs.3.rs-25078/v1
“Identifying prediabetes and addressing related cardiovascular risk factors such as hypertension is important and urgent to reduce cardiovascular and renal burdens, which was recommended by recent modifications to the US Preventive Services Task Force diabetes screening guideline [38].”
BackgroundBishop, D. B., O’Connor, P. J., Kidney, R. S. M., & Haire-Joshu, D. L. (2016) · American Public Health Association eBooks · doi:10.2105/9780875532783ch12
The Effect of Blood Sugar Fasting Levels on Diabetic Dyslipidemia
Yasmin, R., Ahmed, A., Javed, A., Asim, M., Shabbir, R., Mushtaq, S., & Irshad, F. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164360
Robertson, M. L., & Colburn, J. L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.004
Application of Longitudinal Data the Multilevel Models Approach on Diabetes Mellitus
Moges, W. K., & Endalamaw, T. M. (2023) · Journal of Health Science and Medical Research · doi:10.31584/jhsmr.2023936
Health Maintenance and Prevention
Gestuvo, M. K. (2023) · Springer eBooks · doi:10.1007/978-3-030-01782-8_111-1
Screening of Prediabetic Patients by using HbA1c in District Narowal Pakistan
Kaream, K. F., Ashraf, S., Awais, M. U., Shabbir, A., Irshad, F., & Ehsan, H. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i1.291
Physical Activity Behavioral Intervention for type 2 DM Patients: A Literature Review
Zainuddin, Z., Jusuf, H., Sarinah Basri, K., & Ilham, R. (2023) · International Journal of Public Health Excellence (IJPHE) · doi:10.55299/ijphe.v3i1.633
Wong, S. J. K. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/173234
Metadata
- Authors
- Siu, A. L., & on behalf of the U.S. Preventive Services Task Force*
- Affiliations
- United States Preventive Services Task Force (US)
- Corresponding author
- Siu, Albert L.
- ORCID
- Siu, Albert L.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2015-12-01
- Volume
- 163
- Issue
- 11
- Pages
- 861-868
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2184512969
- Semantic Scholar
- d2283e77e36b23e882188941e6140255c0dc9669
- Cited by
- 319
- References
- 49
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 16 · 2023: 30 · 2022: 16 · 2021: 56 · 2020: 40 · 2019: 27 · 2018: 39 · 2017: 42 · 2016: 32 · 2015: 1
- FWCI
- 40.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, diabetes screening, impaired fasting glucose, impaired glucose tolerance, abnormal blood glucose, asymptomatic adults, overweight and obesity, cardiovascular risk assessment, behavioral counseling, primary care
- MeSH terms
- Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Mass Screening, Middle Aged, Cost of Illness, Risk Assessment, Glucose Metabolism Disorders, Asymptomatic Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.